Reported Consolidated quarterly numbers for Pharmaids Pharmaceuticals are:
Net Sales at Rs 8.61 crore in September 2025 up 64.24% from Rs. 5.24 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.48 crore in September 2025 down 11.72% from Rs. 2.22 crore in September 2024.
EBITDA stands negative at Rs. 5.10 crore in September 2025 down 100% from Rs. 2.55 crore in September 2024.
Pharmaids Pharm shares closed at 46.99 on November 18, 2025 (BSE) and has given -30.83% returns over the last 6 months and -35.66% over the last 12 months.
Story continues below Advertisement
| Pharmaids Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 8.61 | 6.66 | 5.24 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 8.61 | 6.66 | 5.24 | | EXPENDITURE | | Consumption of Raw Materials | 9.84 | 1.92 | 2.36 | | Purchase of Traded Goods | 0.45 | 1.23 | 1.10 | | Increase/Decrease in Stocks | -2.74 | 0.36 | 0.05 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.18 | 4.19 | 2.87 | | Depreciation | 0.47 | 0.61 | 0.61 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.20 | 4.38 | 1.41 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -5.79 | -6.02 | -3.17 | | Other Income | 0.22 | 0.04 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -5.57 | -5.98 | -3.16 | | Interest | 1.08 | 1.20 | 0.33 | | P/L Before Exceptional Items & Tax | -6.65 | -7.17 | -3.49 | | Exceptional Items | 2.99 | 0.00 | -0.07 | | P/L Before Tax | -3.66 | -7.17 | -3.56 | | Tax | -1.13 | -1.86 | -1.00 | | P/L After Tax from Ordinary Activities | -2.53 | -5.32 | -2.56 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.53 | -5.32 | -2.56 | | Minority Interest | 0.05 | 0.36 | 0.34 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -2.48 | -4.95 | -2.22 | | Equity Share Capital | 35.27 | 35.27 | 35.27 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.70 | -1.41 | -0.73 | | Diluted EPS | -0.70 | -1.41 | -0.73 | | EPS After Extra Ordinary | | Basic EPS | -0.70 | -1.41 | -0.73 | | Diluted EPS | -0.70 | -1.41 | -0.73 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
